BBIO - CIK 0001743881
BridgeBio Pharma, Inc. has filed 777 documents with the SEC between 2018 and 2026. The most frequent type is insider trade (386 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2025-05-19 | - |
| SCHEDULE 13D/A | - | 2025-05-14 | - |
| Insider trade | 4 | 2025-05-14 | 2025-05-12 |
| Insider sale notice | 144 | 2025-05-12 | - |
| Proxy materials | DEFA14A | 2025-05-09 | - |
| Insider trade | 4 | 2025-05-09 | 2025-05-07 |
| Insider trade | 4 | 2025-05-06 | 2025-05-02 |
| Insider trade | 4 | 2025-05-06 | 2025-05-02 |
| Insider sale notice | 144 | 2025-05-02 | - |
| Proxy materials | DEFA14A | 2025-04-30 | - |
| Annual report to shareholders | ARS | 2025-04-30 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-04-30 | 2025-06-20 |
| Quarterly report | 10-Q | 2025-04-29 | 2025-03-31 |
| Major company event | 8-K | 2025-04-29 | 2025-04-29 |
| Insider trade | 4 | 2025-04-24 | 2025-04-22 |
| PRE 14A | - | 2025-04-16 | 2025-06-20 |
| Insider trade | 4 | 2025-04-16 | 2025-04-14 |
| Insider sale notice | 144 | 2025-04-14 | - |
| Insider trade | 4 | 2025-04-03 | 2025-04-01 |
| Insider sale notice | 144 | 2025-04-02 | - |
| Insider trade | 4 | 2025-03-27 | 2025-03-25 |
| Insider trade | 4 | 2025-03-21 | 2025-03-19 |
| Insider trade | 4 | 2025-03-21 | 2025-03-19 |
| Insider trade | 4 | 2025-03-21 | 2025-03-19 |
| Major company event | 8-K | 2025-03-17 | 2025-03-17 |
| SCHEDULE 13D/A | - | 2025-03-12 | - |
| Insider trade | 4 | 2025-03-10 | 2025-03-06 |
| SCHEDULE 13D/A | - | 2025-03-07 | - |
| Insider trade | 4 | 2025-03-07 | 2025-03-05 |
| Insider sale notice | 144 | 2025-03-06 | - |
| Insider sale notice | 144 | 2025-03-05 | - |
| Major company event | 8-K | 2025-02-28 | 2025-02-24 |
| New insider ownership | 3 | 2025-02-27 | 2025-02-19 |
| Insider trade | 4 | 2025-02-27 | 2025-02-25 |
| Insider trade | 4 | 2025-02-27 | 2025-02-25 |
| Insider sale notice | 144 | 2025-02-25 | - |
| Insider sale notice | 144 | 2025-02-25 | - |
| Annual report | 10-K | 2025-02-20 | 2024-12-31 |
| Major company event | 8-K | 2025-02-20 | 2025-02-20 |
| Insider sale notice | 144 | 2025-02-19 | - |
| Insider sale notice | 144 | 2025-02-19 | - |
| Insider trade | 4 | 2025-02-19 | 2025-02-16 |
| Insider trade | 4 | 2025-02-19 | 2025-02-16 |
| Insider trade | 4 | 2025-02-19 | 2025-02-16 |
| SCHEDULE 13G/A | - | 2025-02-13 | - |
| SCHEDULE 13D/A | - | 2025-01-31 | - |
| Insider sale notice | 144 | 2025-01-31 | - |
| Insider trade | 4 | 2025-01-31 | 2025-01-31 |
| Insider trade | 4 | 2025-01-30 | 2025-01-28 |
| Insider trade | 4 | 2025-01-30 | 2025-01-28 |